#news #biotech Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B .Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B
badams
Wed, 07/28/2021 – 04:30

from FierceBiotech: Biotech https://ift.tt/2UOQK8A